BMS-212
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
glucokinase (GK)
Description:
BMS-212 is a potent and selective stimulator of glucokinase (GK) (EC50 = 35 nM) that is promisingly used as an antidiabetic. BMS-212 has a preference for GK in liver over GK in pancreas, of which the activation may lead to non-glucose-dependent insulin secretion. Half-life of BMS-212 is 4.2h, and oral bioavailability is 15%.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
stimulator of glucokinase (GK), potential antidiabetic
MSDS:
Inquire
Application:
potential antidiabetic
Current Developer:
Bristol-Myers Squibb
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Quick Inquiry

Verification code

Featured Items